Monoclonal antibodies to Naegleria fowleri and Acanthamoeba polyphaga were analyzed by enzyme-linked immunosorbent assay, indirect immunofluorescence microscopy, and fluorescence flow cytometry to assess specificity and cross-reactivity with axenically cultured N. fowleri and Acanthamoeba spp. Four monoclonal antibodies to N. fowleri were specific for N. fowleri and had no reactivity to A. polyphaga. Similarly, four monoclonal antibodies to A. polyphaga did not react with N. fowleri. Two of the four monoclonal antibodies to A. polyphaga did not react with other Acanthamoeba spp. tested, while two of the antibodies demonstrated a high degree of cross-reactivity with a putative Acanthamoeba castellanii strain by immunofluorescence microscopy; this was confirmed by fluorescence flow cytometry for one of the antibodies. These monoclonal antibodies were used to identify Acanthamoeba trophozoites in infected brain sections of a patient who died of suspected Acanthamoeba-caused granulomatous amoebic encephalitis, demonstrating potential utility in the direct identification of N. fowleri and Acanthamoeba spp. in clinical specimens.
Naegleria fowleri and Acanthamoeba species are the causative agents of primary amoebic meningoencephalitis and granulomatous amoebic encephalitis, respectively (4, 7, 13, 16, 22, 29) . In addition, keratitis due to Acanthamoeba species in contact lens wearers has become increasingly common (1, 10, 17) . These ubiquitous organisms are found in freshwater lakes, streams, and ponds; thermally polluted water; warm springs; soil; and chlorinated pools (7, 8, 18, 20, 22, 38) . N. fowleri infects healthy individuals after swimming or other types of exposure to contaminated waters. In contrast, Acanthamoeba infection of the central nervous system occurs in debilitated or immunocompromised individuals (including those with acquired immunodeficiency syndrome) and is usually not associated with exposure to contaminated water (2-4, 9, 11, 15, 21, 25, 27, 29, 39) . The neurologic diseases produced by N. fowleri and Acanthamoeba species, as well as Acanthamoeba keratitis, are difficult to diagnose and are refractory to treatment (1, 4, 10, 22) . Although the outcome of both central nervous system diseases is usually fatal, the clinical courses are dramatically different. The clinical course of Naegleria neurologic infection has a sudden onset and a fulminant course due to diffuse hemorrhagic necrotizing meningoencephalitis, while Acanthamoeba neurologic infection is usually manifested with a subacute-to-chronic illness with signs of increased intracranial pressure and focal neurologic deficit due to granulomatous brain lesions (4, 16, 22, 25) . However, there are several reports of primary amoebic meningoencephalitis due to Acanthamoeba spp. (2, 11, 39) .
Only two cases of survival because of successful drug therapy in patients with primary amoebic meningoencephalitis have been reported, both in instances in which therapy was initiated early (12, 27) . Thus, early diagnosis may be critical to ensuring a favorable prognosis. In this report, we demonstrate the potential clinical utility of monoclonal antibodies to N. fowleri and Acanthamoeba polyphaga as diag-* Corresponding author. nostic tools. In addition, the monoclonal antibodies specific for A. polyphaga may be useful in the classification of Acanthamoeba spp., which is occasionally based on morphologic criteria alone (14, 35) . We used indirect immunofluorescence microscopy with axenic organisms and infected brain sections and enzyme-linked immunosorbent assay (ELISA) to assess the specificity of the monoclonal antibodies. In addition, fluorescence flow cytometry was used to corroborate the data obtained. (32) .
MATERIALS AND METHODS
Production of monoclonal antibodies. Monoclonal antibodies to N. fowleri and A. polyphaga were produced by the method of Kohler and Milstein (19) . For immunization, BALB/c mice were intraperitoneally injected with 107 Formalin-fixed organisms in PBS with no adjuvant, rested 14 days, reimmunized intraperitoneally, rested 14 days, and sacrificed 3 days after a final intravenous boost with 104 organisms. Fusions were performed by using spleen cells of immunized mice and the NS-0 myeloma cell line (19) . Screening of wells was performed by ELISA as described previously (32, 33) . The feeding, minicloning, cloning by limiting dilution, and production of ascitic fluid were performed as described previously for production of monoclonal antibodies to Trichomonas vaginalis and Entamoeba histolytica (32, 33 Tween 20 (PBS-Tween). The plates were incubated for 1 h at 37°C and washed four times in PBS-Tween, and 50 ,ul of a 1:1,000 dilution of peroxidase-conjugated affinity-purified rabbit anti-mouse immunoglobulin (Zymed, San Francisco, Calif.) was added to each well. The plates were incubated for 1 h at 37°C, washed four times in PBS-Tween, washed two times in PBS, and developed for 30 min in a phosphate-citrate buffer (pH 5.0) with o-phenylenediamine and peroxidase. Positive controls included rabbit polyclonal anti-Naegleria serum and rabbit polyclonal anti-A. polyphaga serum with peroxidase-conjugated goat anti-rabbit immunoglobulin (Zymed). Negative controls included monoclonal antibody specific for T. vaginalis and monoclonal antibody specific for E. histolytica with peroxidase-conjugated rabbit anti-mouse immunoglobulins (Zymed).
Indirect immunofluorescence microscopy. Briefly, for indirect immunofluorescence microscopy, 5 x 10' trophozoites fixed in 1% Formalin were placed onto glass slides with a pipette and allowed to dry at 370C for 1 h. The organisms were fixed to the glass slides by being fixed in acetone for 10 min and then covered with monoclonal antibody-bearing ascitic fluid, protein A-purified monoclonal antibody, or rabbit polyclonal antiserum, which were diluted in PBS containing 1% bovine serum albumin. The slides were incubated in a moist chamber for 1 h, washed three times in PBS, and covered with an appropriate dilution of fluoresceinconjugated rabbit anti-mouse immunoglobulin (Zymed) or fluorescein-conjugated goat anti-rabbit immunoglobulin (Zymed) . The optimal concentrations of antigen, primary monoclonal antibody, and fluorescein conjugate were determined by block titration. After incubation for 30 min in a moist chamber at 37°C, the slides were washed three times in PBS and allowed to air dry (in the dark), and cover slips were mounted with a glycerol mounting fluid (Difco Laboratories, Detroit, Mich.). The slides were subsequently examined for fluorescence by using a Leitz fluorescence microscope and scored as 0 to 4+ according to fluorescence intensity; 4+ indicated extremely bright apple green fluorescence; negative samples were scored as 0. Controls consisted of fluorescence conjugate only or monoclonal antibodies specific for T. vaginalis or E. histolytica plus fluorescein conjugate. These monoclonal antibodies were demonstrated to have no reactivity to Acanthamoeba spp. or N. fowleri by ELISA (data not shown).
The slides of brain sections were treated essentially as described above. Four monoclonal antibody-bearing ascitic fluids specific for Acanthamoeba spp. (AC2B, AC3B, AC7B, and AC9B) or four monoclonal antibody-bearing ascitic fluids specific for N. fowleri (N3B, N4A, N5A, and N6A) were pooled and used at a 1:100 dilution. Negative controls included fluorescein conjugate only and uninfected brain sections stained with each pool of monoclonal antibodies followed by staining with fluorescein conjugate. Positive controls included rabbit anti-A. polyphaga serum and rabbit anti-N. fowleri serum, which were tested at a 1:500 dilution.
Flow cytometry. For flow cytometry, 106 Formalin-fixed A. polyphaga, "A. castellanii," or N. fowleri cells were suspended in 1 ml of PBS to which was added 0.5 ml of monoclonal antibody-bearing ascitic fluid or protein A-purified monoclonal antibody (1 mg/ml), and the suspensions were incubated for 1 h at 37°C with occasional gentle agitation. The cells were washed four times in ice-cold PBS, suspended in 0.5 ml of a solution of fluorescein-conjugated rabbit anti-mouse immunoglobulin (diluted 1:20), and incubated at 37°C for 1 h with occasional gentle agitation. The cells were washed four times in ice-cold PBS, suspended in 1 ml of PBS, and analyzed immediately by flow cytometry. Fluorescence activity was measured on a Coulter Epics 751 fluorescence-activated cell sorter (Coulter Electronics, Inc., Hialeah, Fla.) using a single 488-nm-wavelength argon laser operated at 200 mW. Analysis of antibody specificity and cross-reactivity was performed by using the computer program IMMUNO from Coulter.
RESULTS
Monoclonal antibodies and isotypes. Eight monoclonal antibodies produced to either A. polyphaga (AC2B, AC3B, AC7B, and AC9B) or N. fowleri (N3B, N4A, NSA, and N6A) were used in this study. The isotypes of the monoclonal antibodies and organisms used to generate the antibodies are listed in Table 1 . Monoclonal antibodies used as controls have been described elsewhere (32, 33) .
ELISA. The immunological specificities of the eight monoclonal antibodies to A. polyphaga or N. fowleri were initially determined by ELISA. The four anti-A. polyphaga monoclonal antibodies did not react with N. fowleri. Similarly, the four anti-N. fowleri monoclonal antibodies did not react with A. polyphaga ( Fig. 1 ; data shown for N3B and AC2B only). 
IgM
In addition, monoclonal antibodies did not react with medium components demonstrating specificity to the organisms (data not shown). Indirect immunofluorescence. We tested the reactivities of the eight monoclonal antibodies to three species of Acanthamoeba (A. polyphaga, "A. castellanii," and A. culbertsoni) and one strain of N. fowleri. Anti-N. fowleri monoclonal antibodies were specific for N. fowleri ( Fig. 2A and 3A ; data shown for N3B only) and did not cross-react with the three Acanthamoeba species tested ( Fig. 3 ; data shown for A. polyphoga). The four monoclonal antibodies generated to A. polyphaga demonstrated 4+ fluorescence with A. polyphaga ( Fig. 2B ; data shown for AC2B) and did not react with A. culbertsoni ( Table 2 ). In addition, two of the anti-A. polyphaga monoclonal antibodies (AC7B and AC9B) reacted with the "A. castellanfi" strain (Table 2) .
Brain sections from a patient diagnosed as having Acanthamoeba-caused granulomatous amoebic encephalitis by histopathologic and clinical criteria were tested by indirect immunofluorescence with a pool of A. polyphaga-specific monoclonal antibodies (1:100), a pool of N. fowleri-specific monoclonal antibodies (1:100), rabbit polyclonal anti-A. polyphaga serum (1:500), and rabbit polyclonal anti-N. fowleri serum (1:500). The pool of anti-Acanthamoeba monoclonal antibodies reacted with trophozoites but not 2.0 with cysts in the infected brain sections and failed to react with uninfected brain tissue (Fig. 4) . Approximately five trophozoites were seen per brain section; however, numerous unstained cysts were present. In contrast, the pool of N. fowleri monoclonal antibody-bearing ascitic fluids did not react with the cysts or trophozoites in the infected brain sections or with uninfected brain sections (data not shown). When infected brain sections were stained with rabbit polyclonal antiserum, anti-A. polyphaga serum demonstrated 4+ fluorescence with trophozoites while anti-N. fowleri serum detected trophozoites which were weakly fluorescent (1+) (data not shown). Rabbit polyclonal antisera did not react with cysts present in the infected brain sections or with uninfected brain sections.
Flow cytometry. The visual interpretations of immunofluorescence reactivity of monoclonal antibodies with axenic organisms were analyzed and quantitated by fluorescence flow cytometry. Ninety-degree-light-scatter-versus-forwardangle-light-scatter profiles were used to assess the homogeneity of cell populations by cell complexity and size (Fig. 5) . Flow cytometry detected fluorescence in 99.6% ofN. fowleri cells when they were reacted with monoclonal antibody N3B (Fig. 6A) and 94% of A. polyphaga cells when they were reacted with AC2B (Fig. 6B) . In contrast, there was no significant degree of fluorescence measured by N3B reacted against A. polyphaga organisms (Fig. 6B, inset 2) . This demonstrated the specificity of N3B for N. fowleri and corroborated the data obtained from slide IFA. Conversely, when antibody specific for A. polyphaga was tested against N. fowleri, a low degree of fluorescence was detected, demonstrating that the monoclonal antibody did not crossreact with N. fowleri (Fig. 6A, inset 2) . Similarly, when three VOL. 28 monoclonal antibodies (AC2B, AC3B, and AC7B) generated to A. polyphaga were analyzed by flow cytometry, each demonstrated a high degree of fluorescence with A. polyphaga. Monoclonal antibodies AC2B and AC3B showed little or no fluorescence with "A. castellanii" (Fig. 7A and  B, insets 2) . However, the degrees of fluorescence of monoclonal antibody AC7B with A. polyphaga and with "A.
castellanii" were similar (Fig. 7C, insets 1 and 2 , respective- ly). The histograms (Fig. 7A to C ) demonstrate the percent difference in fluorescence between A. polyphaga and "A. castellanii" after subtraction of fluorescence data of inset 2 from inset 1. The percent difference in staining of monoclonal antibody AC7B to A. polyphaga and "A. castellanii" was 42, indicating a high degree of cross-reactivity, while the percent difference in staining of monoclonal antibody AC2B or AC3B was 91, indicating little or no cross-reactivity. circumstances, and require different drug treatments, there are few tests available for their rapid identification and differentiation. Current methods for rapid detection of amoebae in tissue or corneal scrapings include Giemsa, Gomori, and iron-hematoxylin-eosin stains (1, 22) . However, these techniques require highly trained personnel and a strong clinical suspicion of amoebic infection to identify organisms in stained specimens. Novel fluorescent stains such as Calcofluor white and fluorescein-conjugated lectins have also been used to stain corneal scrapings for Acanthamoeba spp. (26, 28) . Indirect immunofluorescence with rabbit polyclonal antiserum has been used for staining tissue in suspected cases of amoebic meningoencephalitis or keratitis (10, 11, 36, 39) , but considerable cross-reactivity has been reported (36) and the sensitivity of these antibodies is suspect. Clearly, reagents which specifically detect these organisms in clinical specimens and can identify Acanthamoeba spp. to the species level are needed.
In a previous report, Visvesvara et al. (37) 28, 1990 on (6) .
These monoclonal antibodies are also potentially of benefit in the clinical diagnosis of Acanthamoeba keratitis. Keratitis due to Acanthamoeba spp. has been frequently confused with herpes simplex virus stromal keratitis, resulting in delays in proper treatment (1, 10) . Drug therapy alone is usually ineffective and susceptibilities to antimicrobial agents vary among different strains and species of Acanthamoeba (1, 10, 24, 30, 31) . Since penetrating keratoplasty is usually most effective when performed prior to extensive corneal involvement (1, 10) , early identification of Acanthamoeba infection is crucial.
Studies are under way to characterize these antibodies with respect to antigenic recognition by immunoprecipitation of metabolically labeled organisms (the monoclonal antibodies do not immunoblot) and to determine their reactivities with larger numbers of both Naegleria and Acanthamoeba strains and species, as well as to generate monoclonal antibodies to other species of Acanthamoeba.
